News

As Novo Nordisk Ramps up Lawsuits Over Wegovy Copies, Investors Ask Where Is Hims?

A Novo spokesperson said the Danish drugmaker was not ruling out further legal action after announcing new lawsuits against ...

HSBC Raises Novo Nordisk (NVO) Price Target on Oral Semaglutide Market Share Boost

Novo Nordisk A/S (NYSE:NVO) is one of the best falling stocks to buy now. On August 7, HSBC maintained a “Hold” rating on ...

Novo Nordisk CEO warns of layoffs as Wegovy challenge heats up

Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug this year and could ...
BioSpace17h

A Compounding Problem: How GLP-1s Drove Novo Nordisk’s Rapid Rise and Fall

Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...
Al Jazeera on MSN7d

Wegovy maker Novo Nordisk warns of layoffs as competition grows

Novo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be ...

Novo Nordisk’s Wegovy Weight-Loss Drug Sales Surge Despite Copycat Issues

Second-quarter sales of the blockbuster drug soared 67% on year, despite millions of U.S. patients using generic unbranded ...
Investor's Business Daily on MSN7d

Novo Nordisk Slumps As It Cautions 'Unsafe And Unlawful' Knockoffs Will Pressure Wegovy

Novo Nordisk stock slumped Wednesday after saying it expects compounded versions to undercut sales of its obesity drug, ...
Devdiscourse1d

Healthcare Highlights: Assura Bid, Wegovy Lawsuits, and AI in Hospitals

This article covers key health news including Primary Health Properties securing a takeover bid for Assura, Novo Nordisk's ...

Novo Nordisk Shares Plummet as Competition Weighs on Sales

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

Why I Tripled My Novo Nordisk Position

Novo Nordisk's steep stock decline has pushed it into deep undervaluation, now trading at attractive multiples below ...